Allspring Global Investments’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,811
Closed -$18.7K 2834
2023
Q3
$18.7K Sell
7,811
-568
-7% -$1.26K ﹤0.01% 2522
2023
Q2
$19.4K Buy
8,379
+1,320
+19% +$3.73K ﹤0.01% 2466
2023
Q1
$18K Sell
7,059
-10,408
-60% -$29.8K ﹤0.01% 2519
2022
Q4
$43.8K Sell
17,467
-382
-2% -$1.07K ﹤0.01% 2375
2022
Q3
$51K Buy
+17,849
New +$75.1K ﹤0.01% 2353

Other funds holding SLGC

Allspring Global Investments's SLGC Position: Q4 2023 in Review

Allspring Global Investments sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 7,811 shares — an estimated $18.7K sold.

Allspring Global Investments first reported a position in SLGC in Q3 2022 and held it in 5 quarters. The position peaked at $51K in Q3 2022. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Allspring Global Investments reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 7,811 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $18.7K.
  • Allspring Global Investments first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2022 and held it in 5 quarters.
  • Allspring Global Investments's SomaLogic, Inc. Class A Common Stock position peaked at $51K in Q3 2022.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.